Globin Solutions, a poisoning antidote spinout from University of Pittsburgh, has closed more than $5m in series A funding with investors including UPMC Enterprises, the commercialisation arm of University of Pittsburgh Medical Center.

The round was led by Tus-S&T Service Group, a wholly-owned subsidiary of Tsinghua University’s enterprise arm, TusHoldings.

Globin Solutions is working on an antidote combatting severe carbon monoxide poisoning. A large intake of carbon monoxide can be fatal and can result from situations such as household fires.